Novavax AB
556549-4019ActiveInnovating vaccines using proprietary technology platform and strategic partnerships.
Vaccine Developer / Biotechnology Companynovavax.com
Yleiskatsaus
- 100–199
- Työntekijät
- 500–1000milj SEK
- Liikevaihto
- 1997
- Perustettu
Avainpäättäjät
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Rachel King
Director
David Mott
Director
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Novavax is a company dedicated to developing life-saving vaccine innovations to prevent serious illness and eradicate disease globally. They leverage a proprietary, cutting-edge technology platform featuring recombinant protein-based nanoparticles and their specialized Matrix-M® adjuvant. This platf...
VALNEVA SWEDEN AB